Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3203 Target Snapshot

4-hydroxyphenylpyruvate dioxygenase · SINGLE PROTEIN · Sus scrofa

73Compounds
17Assays
1Approved Drugs
132.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q02110. Use UniProt Q02110 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q02110 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats 4-hydroxyphenylpyruvate dioxygenase as ChEMBL target CHEMBL3203, mapped to UniProt Q02110. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
4-hydroxyphenylpyruvate dioxygenase
SINGLE PROTEIN · Sus scrofa
As of 2026-09-14
ChEMBL target ID
CHEMBL3203
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q02110
4-hydroxyphenylpyruvate dioxygenase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether 4-hydroxyphenylpyruvate dioxygenase is the right protein anchor across sources, using UniProt Q02110 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein Label4-hydroxyphenylpyruvate dioxygenase
UniProt AccessionQ02110
Component TypeProtein
Sequence Length393 aa

4-hydroxyphenylpyruvate dioxygenase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as 4-hydroxyphenylpyruvate dioxygenase, mapped to UniProt Q02110. Sequence length is 393 aa.

Mapped IDQ02110
Review name4-hydroxyphenylpyruvate dioxygenase
OrganismSus scrofa
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC50131.0
KI1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL309664 7.82 IC50 15.0 Preclinical
CHEMBL76394 7.55 IC50 28.0 Preclinical
CHEMBL23622 7.52 IC50 30.0 Preclinical
CHEMBL1337 7.4 IC50 40.0 Approved
CHEMBL23996 7.4 IC50 39.81 Preclinical
CHEMBL308262 7.4 IC50 39.81 Preclinical
CHEMBL73467 7.35 IC50 44.67 Preclinical
CHEMBL72081 7.16 IC50 70.0 Preclinical
CHEMBL307048 7.05 IC50 89.13 Preclinical
CHEMBL26162 6.96 IC50 109.65 Preclinical
Distribution

pChEMBL Value Distribution

19
5.0
3
5.5
18
6.0
16
6.5
17
7.0
11
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

NITISINONE
CHEMBL1337
Approved 2002
Assay Landscape

Assay Landscape

17
Total Assays
76
Tested Compounds
1
Assay Types
Binding — 17 assays, 76 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 14 67 6.0
single protein format 3 9 4.7

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine